You are here

  • Home
  • Archive
  • Volume 69, Issue 2
  • Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis

Article metrics

Article menu

Download PDFPDF

XML
Oesophagus
Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis

 

Online download statistics by month:

Online download statistics by month: August 2019 to March 2024

AbstractFullPdf
Aug 2019597592270
Sep 2019492526188
Oct 2019424420158
Nov 201929829887
Dec 201927927990
Jan 2020755737217
Feb 2020440429168
Mar 2020243236118
Apr 202014313876
May 202018017884
Jun 202014313898
Jul 202012111668
Aug 2020194165242
Sep 2020159147164
Oct 202013412348
Nov 202010910850
Dec 202014012863
Jan 202113813292
Feb 20211039546
Mar 202114714372
Apr 202116715977
May 202113312168
Jun 202114313063
Jul 202113612577
Aug 202113012966
Sep 202120820263
Oct 202119318778
Nov 202122122076
Dec 202117918983
Jan 202216916667
Feb 202229629665
Mar 202220920672
Apr 202220721175
May 202222422593
Jun 2022234228116
Jul 202216315871
Aug 202223623584
Sep 202225825681
Oct 202223922871
Nov 202219918374
Dec 202216015239
Jan 202316515357
Feb 202325725166
Mar 202319217992
Apr 202314813246
May 202318016458
Jun 202316114960
Jul 202320619662
Aug 202315713841
Sep 202316615854
Oct 202313412547
Nov 202328926590
Dec 202314112153
Jan 2024157113106
Feb 20241039850
Mar 2024167151136
Total11966115274976